首页> 外国专利> New lanthanide chelate compounds useful for marking bioactive substance e.g. oligopeptide, oligonucleotide, polynucleotide, oligosaccharide, polysaccharide, phospholipid or peptide nucleic acid, either in solution or on solid phase

New lanthanide chelate compounds useful for marking bioactive substance e.g. oligopeptide, oligonucleotide, polynucleotide, oligosaccharide, polysaccharide, phospholipid or peptide nucleic acid, either in solution or on solid phase

机译:新的镧系元素螯合化合物可用于标记生物活性物质,例如溶液或固相中的寡肽,寡核苷酸,多核苷酸,寡糖,多糖,磷脂或肽核酸

摘要

Lanthanide chelate compounds (I) for marking bioactive substance in solution, are new. Lanthanide chelate compounds of formula (I) for marking bioactive substance in solution, are new. A : reactive group for binding biomolecule, comprising isothiocyanate, bromoacetamido, iodoacetamido, maleimide, 4,6-dichloro-1,3,5-triazinyl-2-amino, pyridyldithiol, thioester, aminooxy, azide, alkyne, hydrazide, amino, carboxylic acid, ester or acid halide; Z 1-Z 3H or an electron donating group; Z 4an electron donating group; Z 5a substituent containing carboxylic acid group, phosphoric acid group or sulfonic acid group; X : linker formed from 1-10 groups of 3-12C alkyl or T; T : phenyl, ethyne-diyl, ethene-diyl, ether, thioether, amide (-CO-NH-, -CO-NR1aa-, -NH-CO- or -NR1aa-CO-), carbonyl, ester, disulfide, sulfonamide (-SO 2-NH-, -NH-SO 2-, -NR1aa-SO 2- or -SO 2-NR1aa-), sulfonyl, phosphate, diaza or tert-amine (-NR1aa-); R1aa : alkyl having less than five C; R1a, R1b, R1c, R1d : carboxylic acid or its salt, or an amide (-CO-NH 2or -CO-NHR1aa); and Ln : terbium, dysprosium, samarium or europium. An independent claim is included for a marking reagent comprising a substituted pyridine compound of formula (II) for marking bioactive substance on the surface of a hard phase. R : -COOR1b or -CONHR1b; R1b : phenyl or benzyl (both optionally substituted) or 1-4C alkyl; Z 5a substituent containing carboxylic acid ester, sulfonic acid or sulfonic acid ester; X : 1-2C alkyl or T; A : reactive group for binding to biomolecule, comprising carboxylic acid or its salt, acid halide, ester or amino acid group of formula (-CH(NHR 2)R 3), or -E-O-PZ-O-R 4, where O is substituted selectively by S; R 2temporary protecting group; Z : Cl or NR 5R 6; R 4protecting group; R 5, R 6alkyl; and E : absent or radical of purine or pyrimidine base, which is bond to O either by the hydrocarbon chain, which is substituted with a protected hydroxyethyl group, or by a furan or pyran ring or their modified derivatives, which enables oligonucleotide synthesis. [Image] [Image].
机译:用于标记溶液中生物活性物质的镧系元素螯合化合物(I)是新的。用于标记溶液中生物活性物质的式(I)镧系元素螯合物是新的。 A:用于结合生物分子的反应性基团,包括异硫氰酸酯,溴乙酰胺基,碘乙酰胺基,马来酰亚胺,4,6-二氯-1,3,5-三嗪基-2-氨基,吡啶基二硫醇,硫代酸酯,氨氧基,叠氮化物,炔,酰肼,氨基,羧酸酸,酯或酰卤; Z 1> -Z 3> H或供电子基团; Z 4>给电子基团; Z 5>含有羧酸基,磷酸基或磺酸基的取代基; X:由1-10个3-12C烷基或T形成的连接基; T:苯基,乙炔二基,乙烯二基,醚,硫醚,酰胺(-CO-NH-,-CO-NR1aa-,-NH-CO-或-NR1aa-CO-),羰基,酯,二硫键,磺酰胺(-SO 2-NH-,-NH-SO 2-,-NR1aa-SO 2-或-SO 2-NR1aa-),磺酰基,磷酸盐,二氮杂或叔胺(-NR1aa-); R1aa:具有小于5个碳的烷基; R1a,R1b,R1c,R1d:羧酸或其盐,或酰胺(-CO-NH 2或-CO-NHR1aa); Ln:,、,sa或euro。包括独立权利要求的标记试剂,该标记试剂包含用于在硬相表面上标记生物活性物质的式(II)的取代吡啶化合物。 R:-COOR1b或-CONHR1b; R1b:苯基或苄基(均被取代)或1-4C烷基; Z 5>含有羧酸酯,磺酸或磺酸酯的取代基; X:1-2C烷基或T; A:与生物分子结合的反应性基团,包括式(-CH(NHR 2>)R 3>或-EO-PZ-OR 4>的羧酸或其盐,酰基卤,酯或氨基酸基团,其中O被S选择性地取代; R 2>临时保护基; Z:Cl或NR 5> R 6>; R 4>保护基; R 5>,R 6>烷基; E:嘌呤或嘧啶碱基的缺失或自由基,其通过被保护的羟乙基取代的烃链或呋喃或吡喃环或其修饰衍生物与O键合,从而能够进行寡核苷酸合成。 [图片] [图片]。

著录项

  • 公开/公告号FR2925053A3

    专利类型

  • 公开/公告日2009-06-19

    原文格式PDF

  • 申请/专利权人 WALLAC OY;

    申请/专利号FR20080007092

  • 申请日2008-12-17

  • 分类号C07D401/12;C07D213/24;G01N33/58;

  • 国家 FR

  • 入库时间 2022-08-21 19:07:16

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号